Proportion with more than one hospitalization in the last 30 days of life
-
Percentage of patients who died from cancer with more than one hospitalization in the last 30 days of life
CBE ID0212
American Society of Clinical Oncology
RAS gene mutation testing performed for patients with metastatic colorectal cancer who receive anti-epidermal growth factor receptor monoclonal antibody therapy
-
Percentage of adult patients (aged 18 and over) with metastatic colorectal cancer who receive anti-epidermal growth factor receptor monoclonal antibody therapy for whom RAS (KRAS and NRAS) gene mutation testing was performed
CBE ID1859
Trastuzumab administered to patients with AJCC stage I (T1c) – III human epidermal growth factor receptor 2 (HER2) positive breast cancer who receive adjuvant chemotherapy
-
Percentage of female patients aged 18 and over with HER2/neu positive invasive breast cancer who are administered trastuzumab
CBE ID1858